WNT3A and malignant colon neoplasm: Importantly, we demonstrated that canonical Wnt3a ligand not only stimulated the β-catenin transcriptional activity in colon cancer cells but, at the same time, activated PLC, promoted Ca2+ mobilization, and induced Rho kinase and PLC-dependent cell migration (8).